Home › Angelman Syndrome › North Carolina
Angelman Syndrome clinical trials in North Carolina
3 studies for Angelman Syndrome are looking for participants at sites in North Carolina.
Cities in North Carolina
CHAMPION: A Study to Evaluate the Efficacy and Safety of Obudanersen (ION582) in Children and Adults With Angelman Syndrome (AS)
- University of North Carolina at Chapel Hill School of Medicine, Carrboro
RecruitingPhase 3
Ages 2 to 50 · All sexes · Updated Sep 28, 2026 · NCT07782827BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
- University of North Carolina at Chapel Hill School of Medicine, Chapel Hill
RecruitingPhase 3
Ages 1 to 50 · All sexes · Updated Sep 10, 2026 · NCT07605429Angelman Syndrome Natural History Study
- The Carolina Institute for Developmental Disabilities, Carrboro
RecruitingObservational study
All ages · All sexes · Updated Apr 3, 2025 · NCT04507997From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.